Krystal Biotech Inc (KRYS)
181.87
+3.77
(+2.12%)
USD |
NASDAQ |
Nov 21, 14:35
Krystal Biotech Price: 181.87 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 176.60 | 181.69 | 173.65 | 178.10 | 180349.0 |
| Nov 19, 2024 | 174.30 | 179.00 | 173.65 | 177.85 | 215830.0 |
| Nov 18, 2024 | 171.37 | 176.44 | 168.88 | 175.64 | 254861.0 |
| Nov 15, 2024 | 178.36 | 178.36 | 169.47 | 170.74 | 351124.0 |
| Nov 14, 2024 | 183.27 | 186.44 | 176.05 | 177.39 | 275010.0 |
| Nov 13, 2024 | 190.12 | 192.69 | 183.62 | 184.22 | 201970.0 |
| Nov 12, 2024 | 195.77 | 199.41 | 186.26 | 187.22 | 258476.0 |
| Nov 11, 2024 | 202.24 | 207.84 | 195.05 | 195.87 | 296436.0 |
| Nov 08, 2024 | 185.03 | 200.89 | 184.86 | 199.61 | 416323.0 |
| Nov 07, 2024 | 182.26 | 190.40 | 182.26 | 185.45 | 202507.0 |
| Nov 06, 2024 | 184.22 | 194.59 | 182.57 | 183.09 | 610115.0 |
| Nov 05, 2024 | 172.48 | 175.96 | 170.65 | 174.41 | 245167.0 |
| Nov 04, 2024 | 164.85 | 173.81 | 163.66 | 170.85 | 802865.0 |
| Nov 01, 2024 | 173.03 | 176.49 | 170.82 | 176.39 | 296896.0 |
| Oct 31, 2024 | 174.99 | 175.92 | 170.09 | 172.53 | 190869.0 |
| Oct 30, 2024 | 174.81 | 175.76 | 172.71 | 175.53 | 111858.0 |
| Oct 29, 2024 | 175.99 | 177.23 | 174.97 | 176.22 | 85217.00 |
| Oct 28, 2024 | 177.27 | 180.16 | 175.71 | 176.89 | 133129.0 |
| Oct 25, 2024 | 176.62 | 181.31 | 175.45 | 175.51 | 129171.0 |
| Oct 24, 2024 | 173.10 | 175.12 | 172.69 | 174.98 | 115570.0 |
| Oct 23, 2024 | 173.90 | 174.10 | 171.68 | 172.75 | 118439.0 |
| Oct 22, 2024 | 177.64 | 177.64 | 174.24 | 175.20 | 142907.0 |
| Oct 21, 2024 | 178.13 | 179.80 | 176.25 | 178.98 | 152571.0 |
| Oct 18, 2024 | 177.01 | 179.63 | 175.74 | 179.19 | 189815.0 |
| Oct 17, 2024 | 178.76 | 178.76 | 176.50 | 176.82 | 111303.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
35.02
Minimum
Mar 18 2020
213.66
Maximum
Jul 26 2024
88.38
Average
71.18
Median
Jan 22 2021
Price Benchmarks
| Bioventus Inc | 11.50 |
| ADMA Biologics Inc | 21.33 |
| Alnylam Pharmaceuticals Inc | 247.27 |
| Amicus Therapeutics Inc | 9.48 |
| Rhythm Pharmaceuticals Inc | 59.40 |
Price Related Metrics
| PE Ratio | 102.17 |
| PS Ratio | 22.15 |
| Price to Book Value | 5.905 |
| Price to Free Cash Flow | 92.16 |
| Earnings Yield | 0.98% |
| Market Cap | 5.231B |
| Operating PE Ratio | 82.38 |
| Normalized PE Ratio | 62.54 |